Active Biotech AB (publ) (ACTI.ST)

Nasdaq Stockholm · Financial statements, TTM figures and earnings dates

In fiscal year 2024 (ended December 31, 2024), Active Biotech AB (publ) reported revenue of SEK 0 and net income of −SEK 39.4M. Annual financial statements are available for fiscal years 2020 to 2024, taken from the company's ESEF annual reports (IFRS).

Open interactive financials →

Key financials

SEK	FY2024 2024-12-31	FY2023 2023-12-31	FY2022 2022-12-31	FY2021 2021-12-31	FY2020 2020-12-31
Income statement
Revenue	SEK 0	SEK 0	SEK 0	SEK 0	SEK 6.7M
Operating income	−SEK 39.8M	−SEK 46.5M	−SEK 57.9M	−SEK 49.8M	−SEK 32.3M
Net income	−SEK 39.4M	−SEK 45.8M	−SEK 58.4M	−SEK 49.8M	−SEK 32.2M
Diluted EPS	−SEK 0.09	−SEK 0.17	−SEK 0.25	−SEK 0.23	−SEK 0.19
Cash flow
Operating cash flow	−SEK 40.4M	−SEK 45.7M	−SEK 54.9M	−SEK 46.2M	−SEK 32.2M
Balance sheet
Cash and equivalents	SEK 27.4M	SEK 36.2M	SEK 41.8M	SEK 53.1M	SEK 26.2M
Total assets	SEK 43.2M	SEK 44.0M	SEK 51.0M	SEK 56.8M	SEK 32.2M
Total liabilities	SEK 10.4M	SEK 13.4M	SEK 16.5M	SEK 10.1M	SEK 10.0M
Shareholders' equity	SEK 32.7M	SEK 30.7M	SEK 34.5M	SEK 46.7M	SEK 22.1M

TTM = trailing twelve months (balance-sheet items at the latest quarter end). Figures in SEK as reported; per-share data adjusted for stock splits.

Annual reports

More on the interactive page

The full ACTI.ST page on Aurora Financial Journal includes every fiscal year since the company began filing structured data, income statement, balance sheet and cash flow statement line by line, charts for every measure, valuation multiples (P/E, P/S, P/B), live price charts and the earnings calendar.

Open ACTI.ST financials →